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Abstract
Background: The global incidence of type 2 diabetes mellitus (T2DM) is increasing. Given the many complications
associated with T2DM, effective management of the disease is crucial. Physical activity is considered to be a key
component of T2DM management. However, people with T2DM are generally less physically active than individuals
without T2DM and adherence to physical activity is often poor following completion of lifestyle interventions. As
such, developing interventions that foster sustainable physical activity is of high priority. Electrically assisted bicycles
(e-bikes) have been highlighted as a potential strategy for promoting physical activity in this population. E-bikes
provide electrical assistance to the rider only when pedalling and could overcome commonly reported barriers to
regular cycling. This paper describes the protocol of the PEDAL-2 pilot randomized controlled trial, an e-cycling
intervention aimed at increasing physical activity in individuals with T2DM.
Methods: A parallel-group two-arm randomized waitlist-controlled pilot trial will be conducted. Forty individuals
with T2DM will be randomly assigned, in a 1:1 allocation ratio, to an e-cycling intervention or waitlist control.
Recruitment and screening will close once 20 participants have been randomized to each study arm. The intervention will
involve e-bike training with a certified cycle instructor and provision of an e-bike for 12 weeks. Data will be collected at
baseline, during the intervention and immediately post-intervention using both quantitative and qualitative methods. In
this trial, the primary interests are determination of effective recruitment strategies, recruitment and consent rates,
adherence and retention and delivery and receipt of the intervention. The potential impact of the intervention on a range
of clinical, physiological and behaviour outcomes will be assessed to examine intervention promise. Data analyses will be
descriptive.
Discussion: This paper describes the protocol for the PEDAL-2 pilot randomized controlled trial. Results from this trial will
provide information on trial feasibility and identify the promise of e-cycling as a strategy to positively impact the health
and behaviour of individuals with T2DM. If appropriate, this information can be used to design and deliver a
fully powered definitive trial.
Trial registration: ISRCTN, ISRCTN67421464. Registered 03/01/2019.
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Background
Type 2 diabetes mellitus (T2DM) is one of the fastest
growing global diseases [1]. In the UK, the prevalence of
diagnosed T2DM is expected to rise from 3.7 million
individuals in 2017 to 5 million by 2025 [2]. T2DM is as-
sociated with micro- and macrovascular complications
and it is estimated that 10% of the NHS annual UK
budget is spent on the treatment of diabetes and its as-
sociated complications [3].
Engaging in regular physical activity is a key component
of T2DM management [4, 5] that can lead to lowering of
glycated haemoglobin (HbA1c) concentration [6]. Physical
activity also independently reduces cardiovascular risk fac-
tors and contributes to weight loss [7]. However, individ-
uals with T2DM have lower levels of physical activity than
individuals without diabetes [8]. Enrolment in structured
lifestyle interventions is effective at increasing physical ac-
tivity; however, when left to self-manage physical activity
behaviour post-intervention, individuals often return to an
inactive state [9–11] or fail to engage in physical activity
of sufficient intensity or volume to positively impact glu-
cose control [12]. With the increasing prevalence of
T2DM, there is a need to develop sustainable interven-
tions that can foster independent sustainable physical
activity at an intensity that is high enough to generate
positive health outcomes.
Active travel represents a potential means through
which to increase physical activity. In the UK, approxi-
mately 50% of all journeys made by car, both for com-
muting and leisure purposes, are between 1 and 5miles
in length [13]. Given that individuals report a willingness
to actively travel distances of 0.5–2 miles by walking [14]
and 1.5–4.7 miles by cycling [15], it is feasible that these
short motorized journeys could be replaced by active
means and potentially increase physical activity [16]. For
example, in healthy adults, active travel, particularly
commuting, is associated with an increase in physical ac-
tivity [17], reduced likelihood of diabetes diagnosis [18],
lower body mass index (BMI) [19] and improved cardio-
vascular health [18]. Among individuals with T2DM, ac-
tive commuting is associated with increased physical
activity and lower BMI [20]. While both walking and
cycle commuting serve to increase physical activity, re-
search suggests that cycling may provide greater health
benefits than walking [21], potentially due to the higher
intensity of activity associated with cycling in compari-
son to walking [22].
Despite these positive health outcomes, rates of active
commuting in the UK, especially cycling, are low in both
the general population and among individuals with
T2DM [20]. There are a number of barriers to regular
cycling that could discourage engagement including
physical constraints associated with hilly terrain and
poor physical fitness as well as a lack of time and the
distance people have to travel to work [23]. These bar-
riers may be accentuated in individuals with T2DM
given their overall lower levels of physical activity.
Electrically assisted bicycles (e-bikes), also known as
Pedelecs, could help to overcome such barriers to regu-
lar cycling by providing electrical assistance only when
the rider is pedalling leading to increased speed with re-
duced physical exertion compared to conventional cyc-
ling. This extra assistance is believed to be the main
motivator for the increased popularity seen in e-bikes
over recent years, particularly among middle- and older-
aged adults [24, 25]. The provision of an e-bike has been
associated with an increase in self-reported physical
activity behaviour of approximately 353 min per week
among inactive individuals [26]. Furthermore, evidence
suggests that e-cycling can replace the sedentary behav-
iour of motorized transportation [27]. Despite the in-
creased assistance, research indicates that among
physically inactive adults riding an e-bike provides phys-
ical activity of at least a moderate-intensity (> 3 METs)
and can lead to improvements in cardiorespiratory fit-
ness [28] and glucose disposal rate [25].
Among individuals with T2DM, a feasibility study re-
ported that the provision of an e-bike for 5 months led
to a 10% increase in power output, a sign of increased
fitness [29] likely to be the result of increased physical
activity. Furthermore, e-cycling was perceived as enjoy-
able with 14 of the 18 participants purchasing the e-
bikes at the end of the study. This study highlights the
promise of e-cycling as a means of increasing physical
activity in individuals living with T2DM. Building on this
work, an adequately powered randomized controlled
trial (RCT), comparing an e-cycling intervention to a
control group is needed to assess the effectiveness of e-
cycling on health and behavioural outcomes among indi-
viduals with T2DM. However, there is currently insuffi-
cient evidence to support a full-scale RCT, nor are there
data to allow estimation of appropriate sample size.
Therefore, a pilot RCT is needed to determine the feasi-
bility of conducting such a trial and to provide key infor-
mation needed for the design of a full-scale RCT trial, if
warranted.
As such, the primary aim of this study is to test the
feasibility of conducting a randomized e-cycling inter-
vention among individuals with T2DM. In order to ad-
dress this aim the primary objectives are to (1) identify
effective methods of recruiting individuals with T2DM;
(2) determine participants’ willingness to be randomized,
study retention rates, adherence to the intervention and
data collection methods and harmful outcomes; (3) as-
sess intervention fidelity; (4) qualitatively examine the
acceptability of the intervention and study procedures to
participants and instructors; and (5) qualitatively exam-
ine participants experiences of e-cycling. The secondary
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aim is to examine the association between the interven-
tion and outcome measures to determine intervention
promise. Accordingly, the secondary objective is to col-
lect data on a range of individual health and behaviour
outcomes in order to estimate the potential effect of the
intervention (based on condition allocation) to inform
outcome selection in future trials.
Methods
Study design
This pilot study is a parallel-group 2-arm, randomized
waitlist-controlled trial comparing an e-cycling interven-
tion (PEDAL-2) against a standard-care waitlist control
among individuals with T2DM. A total of 40 participants
will be randomized in a 1:1 allocation ratio to the two
study arms. The single-centre trial will be conducted in
the city of Bristol, England. Recruitment for the trial will
begin in March 2019. The majority of measures will be
collected at baseline (time 0 (T0)) and immediately
following the intervention period (T1). In addition, data
will be collected in the final week of the e-cycling inter-
vention (physical activity and travel behaviour) and
throughout the intervention (e-cycling time and dis-
tance). Figure 1 shows the study flow diagram and Add-
itional file 1 provides the SPIRIT checklist for reporting
intervention trials.
Ethical approval and data protection
The project has been approved by the NHS Health Re-
search Authority South West/Central Bristol Research
Ethics Committee (Ref: 18/SW/0164) and is sponsored by
the University of Bristol. Any amendments to the protocol
will be authorized by the sponsor (University of Bristol)
and submitted to the REC and HRA for approval. All data
collected in this study will be maintained and stored in
strict accordance with the data protection regulations. All
patient identifiable information (i.e. names, addresses,
dates of birth etc.) will be stored in a database separate
Fig. 1 Flow diagram of the PEDAL-2 trial
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from the database that holds anthropometric measures,
results of blood tests, physiological measures and travel
and physical activity data. Personal data stored on NHS or
university computers will be password protected and only
the study investigators will have access to the passwords.
Personal data on paper files will be stored in a locked fil-
ing cabinet within the Biomedical Research Centre at the
University of Bristol.
Participant recruitment
Recruitment will occur over three settings. These re-
cruitment settings include (1) primary care practices, (2)
diabetes education days in Bristol run by the Diabetes
and Nutrition service and (3) Diabetes UK Support
Groups in Bristol. All primary care practices in the Bris-
tol, North Somerset and South Gloucester Clinical
Commissioning Group will be invited to act as partici-
pant identification sites for the study. All practices that
wish to act as participant identification sites will conduct
databases searches and send study information to all po-
tentially eligible patients. At diabetes education days,
nurses will provide study information sheets to all indi-
viduals attending the session. These education days
occur approximately once a month in Bristol. At the
four Diabetes UK support groups in Bristol, information
about the study will be disseminated by a member of the
research team. Individuals will also be provided with
study information sheets. Individuals who wish to par-
ticipate in the study will be asked to contact the study
team directly by telephone, in writing or by email. Indi-
viduals who contact the research team will be asked how
they learnt of the study. Eligibility will be determined
over the telephone. Individuals deemed eligible will be
asked to get clearance to engage in physical activity and
have their blood pressure taken by their general practi-
tioner. All participants deemed eligible for the study at
this point will be invited for baseline testing. Table 1
outlines the recruitment and assessment schedule for
PEDAL-2.
Eligibility
Individuals will be eligible to participate in the trial if
they meet the following inclusion criteria:
 Clinical diagnosis of type 2 diabetes mellitus
 Aged 30–70 years
Individuals will be ineligible to participate if they meet
any of the following criteria:
 Currently engage in ≥ 150 min of moderate to
vigorous physical activity per week (assessed by the
Get Active Questionnaire [30])
 Currently taking exogenous insulin
 Have uncontrolled hypertension (systolic blood
pressure > 160 mmHg and/or diastolic blood
pressure > 90 mmHg), for which they are not taking
medication
 Have had a myocardial infarction or stroke within
the past 6 months or have evidence of end-stage
renal failure or liver disease
 Have any other contra-indications to exercise
 Are not cleared to engage in physical activity by
their general practitioner
 Are unable to read and communicate in English
Sample size
We aim to recruit and randomize 40 individuals for the
pilot study. This sample size is based on recommenda-
tions for pilot studies which aim to provide an estima-
tion of a standard deviation for use in the sample size
calculation to inform a larger randomized controlled
trial [31, 32]. There are no explicit targets regarding the
number of individuals to be recruited or screened as we
are investigating de novo the feasibility of recruitment
from primary care. Based on recruitment rates in a simi-
lar population and region, we would anticipate a recruit-
ment rate of approximately 30% [33]. Recruitment rates
are anticipated to be slightly lower for a cycling inter-
vention compared to a combined diet and exercise
intervention, with a previous e-cycling feasibility study
reporting a recruitment rate of approximately 20% [29].
Recruitment and screening will close when 20 partici-
pants have been randomized to each of the two study
arms. The number of individuals invited to participate in
the study and the numbers recruited will be recorded.
Based on a previous feasibility study, a retention rate of
approximately 80% is anticipated [29].
Consent
Once participants have been identified as eligible to par-
ticipate in the study, they will be booked in for their
baseline data collection visit at the University of Bristol
(T0). At this first face to face contact a member of the
research team will outline the study procedures, as per
the information sheet. Participants will be advised that
the study is voluntary and that they have the right to
withdraw at any time, without the need for explanation.
After this, individuals who wish to participate will be
asked to read, complete and sign a consent form, which
will be countersigned by the member of the research
team obtaining consent.
Allocation and randomization
Randomization will occur after consent is obtained
and baseline (T0) data has been collected. Forty indi-
viduals will be stratified based on sex and then ran-
domly assigned to either the e-cycling intervention or
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waitlist control in a 1:1 allocation ratio. Permuted
blocks of random size will be used. The Biomedical
Research Centre data manager will generate the ran-
dom allocation sequences which will be accessible
through a password protected web page. Researchers
will enter the participant ID code and sex into the
web page, and a random allocation will be issued.
Researchers will be aware of the group allocation.
Participants will be informed of the group allocation
via telephone by a member of the research team.
Blinding of intervention allocation will not be pos-
sible for any participant involved in the trial. A max-
imum of 20 participants will be randomized to each
of the trial arms.
PEDAL-2 intervention
Intervention content
Intervention content was designed using qualitative data
from one-to-one interviews with participants who took
part in an e-cycling feasibility study conducted in the
summer of 2016 [29]. Interviews were used to identify
barriers and enablers to e-bike use which were then cat-
egorized using the Theoretical Domains Framework
[34]. These barriers and enablers were mapped onto
intervention functions [35], and behaviour change tech-
niques (BCTs; i.e., the active ingredients of an interven-
tion) deemed most appropriate to deliver the
intervention functions were identified. In addition, be-
haviour change techniques identified in the literature as
Table 1 PEDAL-2 SPIRIT diagram displaying study recruitment and measures schedule
*Pre-screening will only occur in GP practices where databases are searched. M month, CO2 carbon dioxide
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significantly impacting upon general physical activity be-
haviour in individuals with T2DM were incorporated
into the intervention design [36, 37]. The utility of these
BCTs in the current intervention was considered with
regard to affordability, practicality, effectiveness, cost-
effectiveness, acceptability, side-effects/safety, and equity
(the APEASE criteria [35]). In the present study, 17 be-
haviour change techniques will be incorporated into the
intervention (see Additional file 2 for intervention con-
tent and associated behaviour change techniques incor-
porated into PEDAL-2).
Instructor training
Four instructors from Life Cycle UK, a Bristol-based cyc-
ling charity who specialize in bicycle training, will deliver
the intervention. All instructors will be disclosure and
barring service checked and first aid qualified. Instruc-
tors are fully qualified National Standard cycle instruc-
tors, and so instructor training will focus on the
behavioural aspects of the intervention content. In train-
ing session one (3 h), instructors will be taught how to
communicate with participants in a way to promote and
encourage behaviour change. Training session two (2 h)
will be focused on reviewing the intervention manual
and discussing the importance of completing interven-
tion activities specified in the manual. Instructors will be
provided with checklists to record and monitor interven-
tion activities and report changes to the intervention
content.
E-bike training
Following baseline measures (T0) participants allocated to
the intervention will complete e-bike training at Life Cycle
UK. The training will consist of two one-to-one sessions.
Training session one is mandatory and will follow the Na-
tional Standard for Cycle Training guidelines for level 1
and 2. Example activities include demonstration of safety
equipment, starting, stopping, making U-turns, and dem-
onstrating decision-making and safe riding strategy. Indi-
viduals’ previous cycling experience will be considered
when conducting the cycling-specific training.
Training session 2 will be optional and will occur
within 2 weeks of session one. The instructor and par-
ticipant will discuss the need or desire for session 2. Ses-
sion 2 will provide participants with an opportunity to
practice e-cycling skills with the instructor. Busier roads
and complex junctions will be incorporated into the ses-
sion if desired by the participant. Training sessions 1
and 2 will last approximately 2 hours each. Throughout
the sessions, the instructors will provide participants
with feedback on their e-cycling and give verbal encour-
agement. Practical e-cycle training will be followed by a
discussion in which instructors will help participants
identify cycle routes, encourage participants to think
about where and when they plan to ride the e-bike and
to set specific e-cycling goals. Participants will be en-
couraged to monitor their e-cycling and will be provided
with a log-book to track activity. Alternatively, instruc-
tors will assist the participant in setting up a mobile
tracking application (Garmin Connect mobile). Instruc-
tors will encourage participants to think about potential
barriers to e-cycling that could arise and brainstorm
strategies to overcome these barriers. Instructors will
also discuss the potential health, social and environmen-
tal consequences of e-cycling. Participants will be invited
to join a private social media group to share their experi-
ences and ride ideas with other individuals participating
in the intervention. Instructors will coordinate this
group.
Following the training (1 or 2 sessions depending on
participants demonstration of appropriate skill level and
confidence) participants will be provided with an e-bike
to take home. E-bikes can be ridden home or, if desired,
transportation of the e-bike will be provided by Life
Cycle UK. Upon taking the e-bike home, participants
will be provided with the following:
 Maps of cycle routes in the area
 Instructions of a call out maintenance service in case
of breakdown
 Helmet, pannier, bike lock and lights
 Garmin edge 130 GPS device to use and track
cycling activity.
E-bike loan
Participants will be loaned an e-bike for 12-weeks. Par-
ticipants will be informed that the e-bike is for use by
themselves and not to be lent to friends or family. Dur-
ing this time, participants will be instructed to use the e-
bike as they desire, this means that no specific daily or
weekly cycling frequency or distance targets will be im-
posed on participants by the researchers. Four weeks
after taking the bike home, participants will attend a ‘re-
fresher’ session with their instructor (session 3). This
session will take place at a location of the participant’s
choice (i.e., at their home or in the local community)
and will last approximately 2 h. The content of the ses-
sion will depend on the participant’s needs but will in-
clude practicing riding skills on established or new
routes and a review of participants e-cycling activity as
well as action planning and goal setting for future rides.
At week 8, the instructor will contact the participant by
telephone to discuss the participants progress, barriers
to e-cycling that have arisen, and strategies used to over-
come them and e-cycling goals for the upcoming month
(session 4). At the end of week 12, participants will be
asked to return the e-bike to Life Cycle UK headquarters
or an instructor will collect the e-bike from the
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participant’s preferred location. Throughout the loan
period, Life Cycle UK will provide a call out e-bike
maintenance service. If required, participants are
instructed to call the maintenance number and a Life
Cycle UK mechanic will come and repair the e-bike.
Control group
Individuals randomly assigned to the waitlist control
after baseline data collection (T0) will receive two phone
calls from the researcher at approximately week 4 and 8
in order to maintain engagement in the study. During
these phone calls, the researcher will direct participants
to diabetes support groups and additional diabetes ser-
vices being offered in the local community, in line with
standard-care procedures. After post-intervention data
collection (T1) these individuals will be offered training
session 1 and loaned an e-bike for 3 months. Sessions 2,
3 and 4 will not be conducted. Participants will be asked
to report any contact they have with other individuals in
the study to ensure no contamination between condi-
tions has occurred.
Measures
Feasibility and acceptability
The following information will be recorded to assess
the feasibility of recruitment through GP practices:
the number of GP practices approached, the number
of practices that agree to participate as participant
identification sites, the number of individuals identi-
fied through database searches and the response rates.
In addition, information on the number of individuals
that attend diabetes education days and the Bristol
Diabetes UK support group will be recorded. Recruit-
ment rates from the three recruitment settings, con-
sent rates and willingness to be randomized will also
be recorded. Retention rates will be determined based
on the number of individuals that complete the inter-
vention and follow-up measures. Adherence rates to
study procedures will be recorded. The acceptability
of the intervention and data collection methodology
will be explored through semi-structured one-to-one
interviews with instructors and all study participants.
These interviews will be conducted by a member of
the research team. Interview questions for instructors
will focus on factors that impact intervention delivery,
including intervention content, facilities, time and
burden. Interview questions for participants will focus
on thoughts and feelings regarding participation in
the intervention and data collection processes. The
project team will track the costs and resources re-
quired in preparation for running the intervention.
Life Cycle UK will track the staff costing of interven-
tion delivery and from the maintenance service.
Process evaluation
We will evaluate whether the intervention was delivered
and received as intended (implementation). This will be
achieved through completion of intervention checklists
by Life Cycle UK instructors and through semi-
structured interviews with instructors and participants
in the intervention group at the end of the intervention.
Intervention intensity, recorded by instructors, will be
determined through recording of the number of inter-
vention sessions attended by participants as well as the
volume of email and telephone contact between instruc-
tors and participants. To explore the mechanisms of im-
pact, semi-structured interviews will be conducted with
participants in the intervention group to identify barriers
and enablers to engaging in e-cycling. These interviews
will help to identify how the intervention impacts be-
haviour and to determine contextual factors that may
influence the intervention.
Assessment of harm
Participants will be asked to report adverse events result-
ing from e-cycling (e.g., musculoskeletal problems, falls
or road traffic accidents) by calling the study phone line.
The number and types of adverse events will be re-
ported. Adverse events that mean the participant is un-
able to continue with the intervention will also be
documented under retention rates. Qualitative inter-
views will be used to explore any unintended conse-
quences that arise from participation in the study.
Outcome measures
Clinical outcomes are those deemed to be of importance
to clinicians in the treatment of T2DM. These outcomes
will be assessed at baseline (T0) and immediately post-
intervention (T1) and include the following:
Anthropometrics. Body weight will be assessed to the
nearest 0.1 kg using digital scales (TANITA Corp,
Tokyo, Japan) and height will be assessed to the nearest
0.1 cm (SECA, 700 SECA, Hamburg, Germany). These
measures will be used to calculate BMI (kg/m2). Waist
circumference will be measured using a non-stretch tape
measure to the nearest 0.1 cm, based on World Health
Organization guidelines [38].
Biochemical variables. Baseline blood samples will be
obtained by cannulation of the antecubital fossa from in-
dividuals in a fasted state (≥ 8 h overnight fast) to meas-
ure glucose, insulin, glycated haemoglobin (HbA1c),
lipids (total cholesterol, high-density lipoprotein choles-
terol, low-density lipoprotein cholesterol and triglycer-
ides) and C-reactive protein. A total of 8 mL of blood
will be taken at this time. After baseline blood samples
participants will complete an oral glucose tolerance test
(OGTT) which will involve consuming 113 mL of Poly-
cal (Nutricia Advanced Medical Nutrition, Trowbridge,
Bourne et al. Pilot and Feasibility Studies           (2019) 5:136 Page 7 of 13
UK) and 87mL of water, equivalent to 75 g of anhydrous
glucose, within 5-min. Further 7 mL blood samples will
be drawn at 15-, 30-, 45-, 60-, 90-, and 120-min inter-
vals. The first 5 mL of each draw will be discarded and
2mL of blood taken for the analysis of glucose and insu-
lin. The intravenous cannula will be kept patent through
flushing with 5 mL 0.9% NaCI (B. Braun, Sheffield, UK).
All blood samples will be transported immediately to the
Bristol Royal Infirmary commercial laboratory and
stored at − 80 °C until analysed. Samples will be analysed
individually as soon as possible after delivery. Glucose,
insulin, lipids and C-reactive protein will be analysed
using a Roche Cobas C701 analyzer (Roche Diagnostics,
Rotkreuz, Switzerland) and HbA1c will analysed using
affinity chromatography. Basal insulin and glucose values
will be used to calculate insulin resistance and beta-cell
function using the Homeostasis Model Assessment cal-
culator (University of Oxford, Diabetes, Trial Unit).
Using values from the OGTT, incremental area under
the curve (iAUC) for insulin and glucose will be calcu-
lated using the trapezoid rule. Glucose and insulin con-
centrations during the OGTT will be used to estimate
insulin sensitivity using the Matsuda index [39]. The
insulinogenic index and oral glucose disposition index
will be used to assess beta-cell function. Once samples
have been analysed, the remainder of the aliquot will be
destroyed by the commercial testing laboratory. Once
the study is complete, any remaining samples will be dis-
posed of in accordance with the Human Tissue Author-
ity’s Code of Practice.
Health-related quality of life. The Short Form 36
Health Survey (SF-36 [40]) is a 36-item inventory de-
signed to assess health-related quality of life (HRQL)
from which 2 measures are derived, a physical compo-
nent summary and a mental component summary. The
physical component summary represents the average of
the scales: physical functioning, role limitations due to
physical health, bodily pain, and general health sub-
scales. The mental component summary score is the
average of the scales which assess energy/fatigue, social
functioning, role limitations due to emotional health,
and emotional wellbeing subscales. Summary scores are
reported in a range from 0 to 100, with a lower score in-
dicating lower quality of life.
Physiological outcomes will be assessed at baseline
(T0) and immediately post-intervention (T1) and include
the following:
Cardiorespiratory fitness will be determined by meas-
uring maximum oxygen uptake (VO2max) using a con-
tinuous incremental ramp maximal exercise test on an
electronically braked cycle ergometer (Lode Excalibur,
The Netherlands). The test will start with a 4-min
warm-up at 30W, with participants cycling at a cadence
of approximately 60 revolutions per minute (rpm).
Following the warm up, the resistance will increase by 1
W every 4 s (15W per minute). The test will be termi-
nated upon volitional exhaustion or when cadence falls
below 50 rpm. Expired gas will be collected continuously
by a metabolic cart (Parvomedics TrueOne 2400, Salt
Lake City, UT, USA). VO2max is defined as the highest
15-s moving average for VO2 (in absolute [l/min] and
relative [ml/kg/min] terms). Criteria for achieving
VO2max will be (1) respiratory exchange ratio > 1.15, (2)
plateau in VO2, (3) reaching age-predicted HRpeak (220-
age); and/or (4) volitional exhaustion. Heart rate will be
monitored using a Polar chest strap, which is integrated
with the metabolic cart and cycle ergometer software
(Lode Exercise Manager). HRpeak and peak power output
(Wpeak) will be recorded as the highest values attained in
the test. Twenty minutes after completing the incremen-
tal VO2max assessment, participants will complete a
supramaximal test to confirm the findings of the incre-
mental assessment. This assessment will follow guide-
lines outlined by Schaun [41]. The multistage test will
consist of a 2-min warm-up at 30W followed by 1 min
at 60% of the incremental VO2max then 110% of incre-
mental VO2max until volitional exhaustion or when ca-
dence falls below 50 rpm [42]. The criteria for achieving
VO2max are the same as those reported above. Differ-
ences of ≤3% will be considered to demonstrate valid-
ation of the incremental VO2max result. The higher of
these two values will be taken as VO2max.
Body composition. Dual-energy x-ray absorptiometry
(Discovery-A; Hologic, Bedford, UK) scans will be used
to assess whole-body and regional fat and lean mass
using the manufacturers software. Peripheral quantita-
tive computer tomography (pQCT; XCT 3000 scanner;
Stratec, Medizintechnik GmbH, Pforzheim, Germany)
will be used to assess intermuscular adipose tissue,
muscle density and muscle cross-sectional area (MCSA)
of the femur at 33% of the limb length. Data from the
pQCT will be analysed using BoneJ [43], a freely avail-
able plugin for the software ImageJ2 [44]. Calibrations of
these machines will be performed daily following manu-
facturers guidelines.
Behavioural outcomes
Physical activity will be measured at baseline (T0) and in
the final week of the e-bike intervention. Participants
physical activity will be assessed for 7 continuous days
using an Actigraph accelerometer (GT3X, Actigraph,
Florida, USA). The Actigraph accelerometer will be
worn on an elasticated belt around the waist and taken
off when sleeping, bathing or swimming. The accelerom-
eter will record raw acceleration data at a sampling fre-
quency of 30 Hz. Raw acceleration data will be processed
using Actilife 6 software to reintegrate the data to 10-s
epochs. Kinesoft software will be used to generate
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outcome variables describing physical activity intensity
using equations developed by Freedson and colleagues
[45], and the frequency and duration of physical activity.
In the current study, the Actigraph accelerometer will be
used to estimate total time spent in moderate-to-
vigorous physical activity (MVPA) before and while hav-
ing access to an e-bike. This measure has been exten-
sively validated in both laboratory and free-living
conditions [46] and has been reported to have a high
completion rate in observational studies [47].
Travel behaviour will be measured at baseline (T0)
and in the final week of the intervention, at the same
time as physical activity monitoring. Spatial location will
be recorded every 5 s using a personal GPS receiver
(QStarz International Co. Ltd., Taiwan). Participants will
be asked to wear the GPS receiver during waking hours
and recharge the device at night. The device can be
worn on the waist or in a pocket as desired. GPS data, in
combination with accelerometer data, will be used to es-
timate (a) the modes of transport used by participants
and (b) the amount of time spent in MVPA attributable
to e-cycling and other modes of active transport.
Raw GPS data will be downloaded using Qtravel soft-
ware (Qstarz International Co. Ltd. Taiwan) and extracted
as csv files. Raw Actigraph acceleration data will be ex-
tracted as csv files using ActiLife 6 software (Actigraph,
FL, USA). Data from these devices will be merged by time-
stamp using an open-source tool, which will (1) classify
different modes of transportation and (2) determine the
amount of MVPA attributable to different active transport
modes in the merged data [48]. This tool has been found
to accurately identify active travel 94.6% of the time in a
cross-validation study. However, the tool has not been val-
idated with e-cycling. As such, participants will be asked to
wear a combined movement sensor and heart rate monitor
(Actiheart®, CamNtech, Cambridge, UK) for the same time
period as wearing the Actigraph monitor and GPS device.
The Actiheart is a waterproof device worn on the left side
of the chest and is attached with standard ECG electrodes.
Accelerometer and heart rate data will be recorded at 15-s
epochs (the shortest epoch available). Fifteen-second accel-
eration and heart rate data from the Actiheart device will
be downloaded using Actiheart 4 software and merged
with the GPS data. These data will be imported into Arc-
GIS for visual inspection and heart rate data will be used
to confirm (or otherwise) identification of e-cycling. Once
e-bike journeys have been identified, this will enable the
estimation of physical activity associated with e-cycling.
Trip purpose
In addition to wearing a personal GPS, participants will
be asked to complete a 7-day travel diary for the same
time period. The travel diary will be adapted from Neves
and Brand [49]. Specifically, participants will be asked to
record the purpose of the trip, travel mode, the start and
end time and the start and end location of each trip.
Participants will be asked to classify their trip under one
of eight categories: commuting, business, education, es-
cort, shopping, visiting friends, entertainment, and recre-
ation. For each journey, participants will be asked to
report the travel mode, walking, cycling, e-biking, bus,
train, car (as driver) and car (as passenger). This diary
will be used to identify the purpose of trips being made
by different transport modes and specifically the purpose
of e-bike use.
Estimated CO2 emissions
Transport-derived CO2 emissions will be calculated by
multiplying the distance travelled by each motorized
mode (determined through GPS and accelerometer data)
by the mode’s average emissions factors following the
procedure outlined by Neves and Brand [49]. For travel
by bus, train and other non-car modes, the total distance
travelled in past week, based on GPS and travel diary
data, will be multiplied by the average emissions factors
based on UK Green House Gases reporting guidelines
[50]. For cars, CO2 emissions will be estimated by consid-
ering the car size (based on engine size), fuel type, vehicle
age, number of cold starts (calculated as the number of
reported trips) and average speed (using GPS data). These
factors underlie the National Atmospheric Emissions
Inventory and will be obtained from DEFRA [50].
E-cycling during the intervention
The number of e-cycling journeys, the distance travelled
on the e-bike and the pattern of e-bike use throughout
the 12-week intervention will be determined through
use of a cycling GPS unit (Garmin Edge 130). The GPS
device will attach directly to the bicycle. Data will be
automatically uploaded to the Garmin Connect website
via Bluetooth connection with the participant’s phone or
manually by the instructor at monthly intervals during
meeting times (if the participant does not wish to track
their e-cycling via the Garmin Connect website). Partici-
pants will be provided with instructions on how to use
the device and a power cable to charge the device. The
e-bike odometer, which is permanently attached to the
bike, will provide a total measure of total distance trav-
elled over the three-months.
Analysis plan
Quantitative analysis
The primary outcomes of this pilot trial include recruit-
ment and consent rates, retention and adherence to study
procedures and data provision. Analysis of these data will
be descriptive, expressed as frequencies and percentages.
Any adverse events will be described appropriately. Char-
acteristics of the sample will be summarized using
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Table 2 List of PEDAL-2 study objectives, associated outcomes, data collection tools, time point measurements and analysis plan
Study objectives Outcome Data collection
method/tool
Time point of measurement Analysis plan
Baseline
(T0)
During
intervention
Follow-
up (T1)
1. Identify effective methods of recruiting
individuals with T2DM
• # GP practices approached; #
that agree to act as PIC
• # individuals identified
through GP database
searches; response rate to
information letters
• # participants recruited from
each recruitment setting
• # individuals that consent to
be part of the study
Study records X Frequencies
and
percentages
2. Determine participants willingness to
be randomized, study retention rates,
adherence to the intervention and data
collection methods and report harmful
outcomes
• # participants retained in
study following
randomization
• # Individuals that complete
follow-up testing
• # of participants that attend
each of the intervention
sessions and data collection
sessions
• # of harmful events
Study records X Frequencies
and
percentages
3. Assess intervention fidelity • # of training sessions
attended by participants and
additional contact with
instructors
• Extent to which intervention
content is completed as
planned
Intervention checklists X Frequencies
and
Percentages
4. Estimate the potential effect of the
intervention on a range of health and
behaviour outcomes to inform outcome
selection in future trials
• Weight, height, BMI Tanita digital scales,
SECA 700
X X Comparison
of change
scores
between
conditions
• Waist circumference Non-stretch tape
measure
X X
• Fasting glucose, insulin,
lipids, C-reactive protein,
HOMA-IR, HOMA-B
8-mL blood sample X X
• OGTT outcomes: iAUC for
glucose and insulin, Matsuda
index, insulinogenic index and
oral glucose disposition index
2 mL blood samples at
15, 30, 45, 60, 90, 120
min post 75 g of
anhydrous glucose
X X Reporting of
effect
estimates
with 95% CI
• Health-related quality of life:
physical and mental summary
Short Form 36 Health
Survey [39]
X X
• Cardiorespiratory fitness Maximum oxygen
uptake using cycle
ergometer
X X
• Body composition: whole-
body fat mass, regional fat
mass, whole-body lean mass,
regional fat mass
Dual-energy x-ray
absorptiometry
X X Comparison
of change
scores
between
conditions
• Femur intermuscular
adipose tissue, muscle density
and muscle cross-sectional
area
Peripheral quantitative
computer tomography
• Total physical activity (time
spent in moderate-to-vigorous
physical activity)
Actigraph (GT3X) X X Reporting of
effect
estimates
with 95% CI
• Moderate to vigorous
physical due to e-cycling and
other modes of active travel
Actigraph (GT3X),
Actiheart and QStarz
GPS
• Transportation modes
(walking, cycling, e-cycling, car,
Actigraph (GT3X),
Actiheart and QStarz
X X
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descriptive statistics (means and standard deviations, me-
dians and interquartile ranges, or frequencies and percent-
ages as appropriate). Descriptive comparisons of these
data will be made between the intervention and the wait-
list control. Evidence of promise of the intervention (i.e.,
whether the intervention can lead to changes in outcomes
measures) will be examined using comparison of change
scores between conditions for all outcome measures (ex-
cept e-cycling during the intervention). See Table 2 for a
description of the outcome measures and proposed ana-
lysis plan for each outcome. Effect estimates will be pre-
sented with 95% confidence intervals reported; p values
will not be considered as the study is not powered to de-
tect effectiveness.
Qualitative analysis
Recordings of interviews will be transcribed verbatim.
An abductive approach to data analysis will be taken
given the interaction between the data and the study
objectives [51], this involves incorporating both de-
ductive and inductive reasoning when analysing the
data. Specifically, using the interview guide as a
framework, deductive content-based analysis will be
conducted to organize initial coding categories based
on the study objectives, that is to determine the ac-
ceptability of the intervention and study procedures
to participants and instructors as well as identify par-
ticipants barriers and facilitators to e-cycling. The-
matic analysis will then be carried out to inductively
explore recurring patterns within subcategories. Con-
tent will be further delineated into sub themes with
similar content. Each transcript will be analysed inde-
pendently by two researchers. Once complete, the two
researchers will compare and discuss coding and
categorization. Any disagreements will be discussed
and resolved through consensus.
The following progression criteria will be used to
guide the decision as to whether to proceed to a defini-
tive trial:
1. At least 20% of potentially eligible individuals
express an interest in being part of the study. This
criterion is based on previous feasibility work
conducted in a similar population [29]. The
proportion of individuals that express an interest in
the study from each recruitment strategy will be
calculated in order to identify the most effective
Table 2 List of PEDAL-2 study objectives, associated outcomes, data collection tools, time point measurements and analysis plan
(Continued)
Study objectives Outcome Data collection
method/tool
Time point of measurement Analysis plan
Baseline
(T0)
During
intervention
Follow-
up (T1)
bus, train) GPS
• Trip purpose (e.g.,
commuting, business,
education, escorting,
shopping, visiting friends,
entertainment, recreation)
Travel diary X X
• Estimated CO2 emissions Actigraph (GT3X) and
QStarz GPS, travel diary
following procedures
by Neves and Brand
[48]
X X
• E-cycling behaviour: # jour-
neys, distance travelled, pat-
tern of e-bike use
Bike odometer and
Garmin 130 GPS
X Mean and SD
Qualitatively examine the acceptability of
the intervention and study procedures to
participants and instructors
• Acceptability of intervention
to participants
• Acceptability of study
procedures to participants
• Acceptability of intervention
delivery to instructors
Semi-structured
interviews
X Thematic
analysis
based on
objective
Qualitatively examine participants
experiences of e-cycling
• Participants barriers and
facilitators to e-cycling
Semi-structured
interviews
X Thematic
analysis
based on
objective
T2DM type 2 diabetes mellitus, GP general practitioner, PIC participant identification center, HOMA-IR Homeostasis Model Assessment for assessing insulin
resistance, HOMA-B homeostatic model assessment for assessing β-cell function, OGTT oral glucose tolerance test, iAUC incremental area under the curve,
CO2 carbon dioxide, CI confidence interval, SD standard deviation
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recruitment method and to determine, where
appropriate, the number of GP practices, Diabetes
Education sessions or Diabetes Support groups that
need to be approached to successfully recruit for a
future trial. The three methods of recruitment will
be compared.
2. At least 80% of eligible individuals (identified
through telephone screening and GP study
clearance) are successfully randomized
3. Attrition of the pilot trial is low, with a study
retention rate of ≥ 80%. This criterion is based on
findings from a previous feasibility study conducted
in a similar population [29].
4. At least 70% of participants in the intervention
group attend at least 60% of the intervention
sessions. This criterion is based on previous
physical activity interventions conducted in
individuals with type 2 diabetes [52].
5. Process evaluation findings suggest that > 80% of
participants report the study methodology to be
comprehensible and acceptable.
Discussion
Physical activity is a key component of managing
T2DM. However, this population is less physically active
than individuals without diabetes. E-cycling has been
found to be an acceptable activity in individuals with
T2DM; however, more research is needed to examine
the feasibility of conducting a randomized controlled
trial and to determine if e-cycling demonstrates a poten-
tial to positively impact both health and behavioural out-
comes. This paper describes the protocol of PEDAL-2, a
pilot randomized waitlist-controlled trial designed to
evaluate the feasibility of conducting an e-cycling inter-
vention in individuals with T2DM. The e-cycling inter-
vention has been developed using previous literature and
semi-structured interviews with the target population. It
is important to acknowledge potential limitations in the
proposed methodology. Specifically, the lack of blinding
may create challenges with study retention particularly
in the control group, potentially creating bias. This is
common to many exercise studies and we have ad-
dressed this by offering all control participants the e-
bike intervention at the end of the trial period. In
addition, this single-centre pilot trial limits the ability to
generalize to other cities across the UK or rural areas in
which the feasibility and associated outcomes could be
different.
Despite these limitations, the data collected in this trial
could be used to inform the development of future e-
cycling interventions and identify appropriate outcome
measures for examination in a definitive trial if deemed
appropriate.
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